MicroRNA dysregulation in the heart and lung of infants with bronchopulmonary dysplasia
- PMID: 37098830
- DOI: 10.1002/ppul.26422
MicroRNA dysregulation in the heart and lung of infants with bronchopulmonary dysplasia
Abstract
BACKGROUND AND OBJECTIVES: Bronchopulmonary dysplasia (BPD) is a serious complication of preterm birth, resulting in significant morbidity and mortality. Recent studies have suggested that microRNA (miRNA) dysregulation is involved in the pathogenesis of BPD and may serve as biomarkers for early detection. We conducted a directed search for dysregulated miRNAs in lung and heart autopsy samples of infants with histologic BPD.
Methods: We used archived lung and heart samples from BPD (13 lung, 6 heart) and control (24 lung, 5 heart) subjects. To measure miRNA expression, RNA was extracted from formalin-fixed, paraffin-embedded (FFPE) tissue specimens then reverse-transcribed, labeled, and hybridized to miRNA microarrays. The microarrays were scanned, and data were quantile normalized. Statistical analysis with a moderated t-test and control of the false discovery rate (5%) was used to compare normalized miRNA expression values between clinical categories.
Results: With our set of 48 samples, 43 miRNAs had a significant difference in expression comparing BPD to non-BPD controls. Among the most statistically significant miRNAs, miR-378b, miRNA-184, miRNA-3667-5p, miRNA-3976, miRNA-4646-5p, and miRNA-7846-3p were all consistently upregulated in both the heart and lung tissues of BPD subjects. The cellular pathway predicted to be most affected by these miRNAs is the Hippo signaling pathway.
Conclusions: This study identifies miRNAs that are similarly dysregulated in postmortem lung and heart samples in subjects with histologic BPD. These miRNAs may contribute to the pathogenesis of BPD, have potential as biomarkers, and may provide insight to novel approaches for diagnosis and treatment.
Keywords: BPD; autopsy; bronchopulmonary dysplasia; extremely preterm; miR; miRNA; microRNA; neonate; neonatology; postmortem; preterm; pulmonology.
© 2023 Wiley Periodicals LLC.
Similar articles
-
MicroRNA expression profiling studies on bronchopulmonary dysplasia: a systematic review and meta-analysis.Genet Mol Res. 2013 Oct 30;12(4):5195-206. doi: 10.4238/2013.October.30.4. Genet Mol Res. 2013. PMID: 24301780
-
Omic-signature of bronchopulmonary dysplasia associated pulmonary hypertension in <1500g-birth-weight-infants with hemodynamically significant intracardiac shunt.Pediatr Res. 2025 Jun;97(7):2341-2346. doi: 10.1038/s41390-024-03541-5. Epub 2024 Sep 13. Pediatr Res. 2025. PMID: 39271902
-
Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia.Am J Physiol Lung Cell Mol Physiol. 2018 Nov 1;315(5):L810-L815. doi: 10.1152/ajplung.00085.2018. Epub 2018 Aug 16. Am J Physiol Lung Cell Mol Physiol. 2018. PMID: 30113227 Free PMC article.
-
Analysis of variable metabolites in preterm infants with bronchopulmonary dysplasia: a systematic review and meta-analysis.Ital J Pediatr. 2024 Nov 14;50(1):246. doi: 10.1186/s13052-024-01812-9. Ital J Pediatr. 2024. PMID: 39543750 Free PMC article.
-
Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.Cochrane Database Syst Rev. 2019 Nov 20;2019(11):CD012024. doi: 10.1002/14651858.CD012024.pub3. Cochrane Database Syst Rev. 2019. PMID: 31745984 Free PMC article.
Cited by
-
Are pre-analytical factors fully considered in forensic FFPE molecular analyses? A systematic review reveals the need for standardised procedures.Int J Legal Med. 2025 Jul;139(4):1439-1452. doi: 10.1007/s00414-025-03480-8. Epub 2025 Apr 2. Int J Legal Med. 2025. PMID: 40172636 Free PMC article.
References
REFERENCES
-
- Thébaud B, Goss KN, Laughon M, et al. Bronchopulmonary dysplasia. Nat Rev Dis Primers. 2019;5(1):78. doi:10.1038/s41572-019-0127-7
-
- Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723-1729. doi:10.1164/ajrccm.163.7.2011060
-
- Hu Y, Xie L, Yu J, Fu H, Zhou D, Liu H. Inhibition of microRNA-29a alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice via upregulation of GAB1. Mol Med. 2019;26(1):3. doi:10.1186/s10020-019-0127-9
-
- Rivera L, Siddaiah R, Oji-Mmuo C, Silveyra GR, Silveyra P. Biomarkers for bronchopulmonary dysplasia in the preterm infant. Front Pediatr. 2016;4:33. doi:10.3389/fped.2016.00033
-
- Nascimento CP, Maia LP, Alves PT, et al. Invasive mechanical ventilation and biomarkers as predictors of bronchopulmonary dysplasia in preterm infants. J Pediatr. 2021;97(3):280-286. doi:10.1016/j.jped.2020.03.006
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources